Magtidelira 33 · Semaglutide & Tirzepatide Hybrid · The Ultimate Weight Loss Pen
33mg Total Compound · Multi-Dose Injectable Pen · UPA Direct Supplier
Benefits · Why Choose Magtidelira 33 Hybrid
Dual-Compound Synergy
Combines Semaglutide and Tirzepatide to target GLP-1, GIP, and Glucagon pathways simultaneously.
Extreme Fat Loss
The hybrid formula provides a multi-angled approach to metabolic enhancement and appetite suppression.
Discrete SA Shipping
Direct-from-supplier delivery across South Africa with professional, temperature-secure packaging.
Product Features
- Hybrid Formulation: 30mg Tirzepatide + 3mg Semaglutide for maximum efficacy.
- Precision Click System: Easily dial in the exact ratio of Tide and Mag as per the protocol.
- Complete Solution: 1x 33mg Pen and 8x needles included in every box.
- Wholesale Pricing: Best price guarantee for public and professional wholesalers in SA.
The Power of the Hybrid · Mechanism
Semaglutide (Mag)
Focuses on potent GLP-1 receptor activation for gastric slowing and sustained satiety.
Tirzepatide (Tide)
Activates both GLP-1 and GIP receptors to improve insulin sensitivity and fat oxidation.
Combined Synergy
The hybrid approach ensures minimal “plateaus” by attacking fat storage from multiple biological pathways.
Dosing Protocol (Once Weekly)
Week 1
20 Clicks
(2mg Tide / 0.2mg Mag)
Week 2
40 Clicks
(4mg Tide / 0.4mg Mag)
Week 3
60 Clicks
(6mg Tide / 0.6mg Mag)
Week 4
80 Clicks
(8mg Tide / 0.8mg Mag)
Week 5
100 Clicks
(10mg Tide / 1.0mg Mag)
Maintenance: 100 Clicks (10mg Tide / 1.0mg Mag)
Technical Specifications · Magtidelira 33
Total Strength:
33mg Hybrid Pen
Volume/Type:
Multi-dose solution for injection
Box Contents:
1x 33mg Pen · 8x Needles
Supplier:
UPA Direct (https://upa.direct)
Medical Disclaimer
These are guideline dosages. Please consult your medical practitioner as to your specific body requirements. Hybrid compounds require strict adherence to medical supervision. Storage: Refrigerate at 2-8°C.
Reviews
There are no reviews yet.